Clinical Trials Shaping the Use of Stem Cell Transplant for Myeloma - 100038

Spotlight
Video

Clinical Trials Shaping the Use of Stem Cell Transplant for Myeloma

patientpower has 2417 videos Subscribe Here

Loading........
Description: Patients who participate in clinical trials not only have an opportunity to receive the latest treatments, but allow research to move forward for everyone. In this interview, from the American Society for Blood and Marrow Transplantation's 2014 BMT Tandem Meetings in Grapevine, Texas, Dr. Sergio Giralt, of Memorial Sloan Kettering Cancer Center, and Dr. Philip McCarthy, of Roswell Park Cancer Institute, review the recent work of the Blood and Marrow Transplant Clinical Trial Network and detail what they hope to achieve through the DETERMINATION trial. With the participation of myeloma patients around the country, this trial may help discover whether induction therapy—the medicine given at the beginning of treatment—with an immunomodulatory drug and a proteasome inhibitor together might prevent some patients from ever needing high-dose chemotherapy using melphalan (Aleran), in conjunction with an autologous stem cell transplant.itor together might prevent some patients from ever needing high-dose chemotherapy using melphalan (Aleran), in conjunction with an autologous stem cell transplant.

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube | http://www.youtube.com/pati...
Like on Facebook | http://www.fb.com/patientpo...
Follow on Twitter | http://www.twitter.com/pati...
Shared By : patientpower
Posted on : 04/16/14
Added : 4 years ago
Category : Multiple Myeloma